Current Pharmaceutical Design
Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Contents
Current Pharmaceutical Design , Volume 21 - Number 32
Editorial
Editorial (Thematic Issue: Controversies in Ocular Pharmacology)
, 21(32): 4659 - 4660Andrzej Grzybowski
DOI: 10.2174/1381612821666150910113126
Controversies in Anticoagulant Therapy in Vitreo-Retinal Surgery
, 21(32): 4661 - 4666Andrzej Grzybowski, Konrad Kupidura-Majewski and Paulina Kupidura
DOI: 10.2174/1381612821666150909095237
Controversies in the Use of Nutritional Supplements in Ophthalmology
, 21(32): 4667 - 4672John G. Lawrenson and Andrzej Grzybowski
DOI: 10.2174/1381612821666150909095916
Controversies in Glaucoma: Current Medical Treatment and Drug Development
, 21(32): 4673 - 4681Claudio Bucolo, Chiara Bianca Maria Platania, Michele Reibaldi, Vincenza Bonfiglio, Antonio Longo, Salvatore Salomone and Filippo Drago
DOI: 10.2174/1381612821666150909095553
Controversies in the Pharmacological Treatment of Uveitis
, 21(32): 4682 - 4687Robert J. Barry and Alastair K. Denniston
DOI: 10.2174/1381612821666150909094907
Controversies in Pharmacological Treatment of Inflammatory Component of Macular Edema
, 21(32): 4688 - 4693Stela Vujosevic and Edoardo Midena
DOI: 10.2174/1381612821666150909095645
Update on Pharmacologic Retinal Vascular Toxicity
, 21(32): 4694 - 4697Stephen G. Schwartz, Andrzej Grzybowski, Weronika Wasinska-Borowiec, Harry W. Flynn and William F. Mieler
DOI: 10.2174/1381612821666150909101621
Intravitreal Steroids for the Prevention of PVR After Surgery for Retinal Detachment
, 21(32): 4698 - 4702Caterina Gagliano, Mario D. Toro, Teresio Avitabile, Santo Stella and Maurizio G. Uva
DOI: 10.2174/1381612821666150909100212
Controversies in Topical Antibiotics Use with Intravitreal Injections
, 21(32): 4703 - 4706Stephen G. Schwartz, Harry W. Flynn and Andrzej Grzybowski
DOI: 10.2174/1381612821666150909101045
Controversies in NSAIDs Use in Cataract Surgery
, 21(32): 4707 - 4717Mikaella-Anthia Tsangaridou, Andrzej Grzybowski, Enken Gundlach and Uwe Pleyer
DOI: 10.2174/1381612821666150909101804
The Role of Atropine Eye Drops in Myopia Control
, 21(32): 4718 - 4730Andrzej Grzybowski, Alejandro Armesto, Maria Szwajkowska, Guillermo Iribarren and Rafael Iribarren
DOI: 10.2174/1381612821666150909095403
Anti-VEGF Molecules for the Management of Diabetic Macular Edema
, 21(32): 4731 - 4737Francesco Bandello, Maria Vittoria Cicinelli and Maurizio Battaglia Parodi
DOI: 10.2174/1381612821666150909095756
Bio-Distribution, Imaging Protocols and Diagnostic Accuracy of PET with Tracers of Lipogenesis in Imaging Prostate Cancer: a Comparison between 11C-Choline, 18FFluoroethylcholine and 18F-Methylcholine
, 21(32): 4738 - 4747Ferdinando Calabria, Gianpasquale Gallo, Orazio Schillaci and Giuseppe Lucio Cascini
DOI: 10.2174/1381612821666150818110422
The Combined Impact of Exhaled Nitric Oxide and Sputum Eosinophils Monitoring in Asthma Treatment: A Prospective Cohort Study
, 21(32): 4752 - 4762Mario Malerba, Alessandro Radaeli, Alessia Olivini, Beatrice Ragnoli, Fabio Ricciardolo and Paolo Montuschi
DOI: 10.2174/1871524915666150710123415
New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung Cancer
, 21(32): 4763 - 4772Paola Claudia Sacco, Paolo Maione, Antonio Rossi, Assunta Sgambato, Francesca Casaluce, Giovanni Palazzolo and Cesare Gridelli
DOI: 10.2174/1381612821666150729120009
Editor-in-Chief
Alessandro Antonelli
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
Biography
Biography of Alessandro Antonelli
Alessandro Antonelli (Professor of Internal Medicine, MD) is Director of the Immuno-Endocrine
Section of Internal Medicine, and Head of the Laboratory of Primary Human Cells, University of
Pisa. His principal areas of expertise are autoimmune thyroid disorders, type 1 diabetes, systemic
autoimmune disorders, chemokines and cytokines, HCV-associated thyroid disorders and thyroid
cancer. His researches have been published in more than 370 articles on International journals
(Impact Factor > 1600; HI=75). He serves as an editorial board member and is Referee and
Reviewer of many scientific International journals.
Executive Editor
Atta-ur-Rahman, FRS
(32052 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography
(32052 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
Biography
Biography of Atta-ur-Rahman
Prof. Atta-ur-Rahman, Ph.D. in organic chemistry from Kings College, University of Cambridge (1968), has 1235 international publications in several fields of organic chemistry including, 349 books published largely by major U.S. and European presses. He was elected as Fellow of Royal Society (London) (2006) and won the prestigious UNESCO Science Prize (1999).
Prof. Atta-ur-Rahman was conferred honorary D.Sc. degrees by many leading world universities including the University of Cambridge and appointed an Honorary Life Fellow of Kings College, University of Cambridge. The Austrian government honoured him with its high civil award (“Grosse Goldene Ehrenzeischen am Bande") (2007). He is Professor Emeritus at the University of Karachi, Pakistan. Prof. Atta-ur-Rahman was appointed Academician (Foreign Member) of the Chinese Academy of Sciences (2015). He won the “Friendship Award of China” (2014) and was conferred the highest scientific award of China, the International Science & Technology Cooperation Award, by President Xi Jinping (2020). He was bestowed with the International Scientific Corporation Award (2014) and the “Einstein Professorship” by the Chinese Academy of Sciences (CAS) (2013). He was also elected as Foreign Member of the Korean Academy of Science and Technology. Research Institutes have been established in his name in China, Malaysia and Pakistan.
Nobel Laureate on Editorial Board
Andrew V. Schally
(USA)
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995. Prof. Alessandro Antonelli serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net